{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T20:24:08Z","timestamp":1794774248971,"version":"4.9.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.arr.2024.102485","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T02:45:21Z","timestamp":1725417921000},"page":"102485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"101","author":[{"given":"Yutong","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102485_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia","volume":"12","author":"Abu-Rumeileh","year":"2019","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10143-021-01678-z","article-title":"S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy","volume":"45","author":"Amoo","year":"2022","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.arr.2024.102485_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib5","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102485_bib6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13195-022-01094-5","article-title":"Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration","volume":"14","author":"Benussi","year":"2022","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib8","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1002\/alz.13157","article-title":"Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid","volume":"19","author":"Bilgel","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-220318","article-title":"A combination of neurofilament light, glial fibrillary acidic protein, and neuronal pentraxin-2 discriminates between frontotemporal dementia and other dementias","volume":"90","author":"Bolsewig","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102485_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104695","article-title":"Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes","volume":"74","author":"Bose","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102485_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/alz.079719","article-title":"Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals","author":"Brum","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib14","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/alz.12879","article-title":"Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: associations with A\u03b2-PET, neurodegeneration, and cognition","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","article-title":"Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy","volume":"93","author":"Chouliaras","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102485_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/acn3.51768","article-title":"Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease","volume":"10","author":"Cousins","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib18","article-title":"Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models","author":"Cullen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib19","doi-asserted-by":"crossref","unstructured":"Deeks JJ, B.P., Leeflang M.M., Takwoingi Y. (editors), 2023. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 2.0 (updated July 2023). Cochrane Available from https:\/\/training.cochrane.org\/handbook-diagnostic-test-accuracy\/current.","DOI":"10.1002\/9781119756194"},{"key":"10.1016\/j.arr.2024.102485_bib20","doi-asserted-by":"crossref","unstructured":"Foley, K.E., Winder, Z., Sudduth, T.L., Martin, B.J., Nelson, P.T., Jicha, G.A., Harp, J.P., Weekman, E.M., Wilcock, D.M., 2023. Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort. Alzheimers Dement.","DOI":"10.1002\/alz.13485"},{"key":"10.1016\/j.arr.2024.102485_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000050753","article-title":"The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia","volume":"46","author":"Fukuyama","year":"2001","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071354","article-title":"Glial fibrillary acidic protein: a biomarker and drug target for Alzheimer's disease","volume":"14","author":"Ganne","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2024.102485_bib23","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.scib.2023.07.009","article-title":"Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China","volume":"68","author":"Gao","year":"2023","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.arr.2024.102485_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102046","article-title":"Novel fluid biomarkers for mild cognitive impairment: a systematic review and meta-analysis","volume":"91","author":"Gaur","year":"2023","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2024.102485_bib25","article-title":"Blood biomarkers for dementia in Hispanic and non-Hispanic White adults","volume":"7","author":"Gonzales","year":"2021","journal-title":"Alzheimers Dement (N. Y)"},{"key":"10.1016\/j.arr.2024.102485_bib26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.51652","article-title":"A population-based meta-analysis of circulating GFAP for cognition and dementia risk","volume":"9","author":"Gonzales","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","article-title":"The dynamics of plasma biomarkers across the Alzheimer's continuum","volume":"15","author":"Guo","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib28","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108624","article-title":"Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease - A systematic review","volume":"107","author":"Heimfarth","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.arr.2024.102485_bib30","doi-asserted-by":"crossref","unstructured":"Jack, C.R., Jr., Andrews, J.S., Beach, T.G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., Molinuevo, J.L., Okonkwo, O.C., Pani, L., Rafii, M.S., Scheltens, P., Siemers, E., Snyder, H.M., Sperling, R., Teunissen, C.E., Carrillo, M.C., 2024. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimers Dement.","DOI":"10.1002\/alz.13859"},{"key":"10.1016\/j.arr.2024.102485_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2022.1740","article-title":"Detection of brain tau pathology in down syndrome using plasma biomarkers","volume":"79","author":"Janelidze","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-023-01168-y","article-title":"Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit","volume":"15","author":"Johnson","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib33","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/clinchem\/hvad139","article-title":"Alzheimer disease biomarkers: moving from CSF to plasma for reliable detection of amyloid and tau pathology","volume":"69","author":"Kang","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.arr.2024.102485_bib34","article-title":"GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102485_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1069411","article-title":"Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment","volume":"14","author":"Kivis\u00e4kk","year":"2023","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102485_bib37","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer's disease","volume":"28","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2024.102485_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104547","article-title":"Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study","volume":"90","author":"Montoliu-Gaya","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2024.102485_bib39","doi-asserted-by":"crossref","unstructured":"Oeckl, P., Anderl-Straub, S., Von Arnim, C.A.F., Baldeiras, I., Diehl-Schmid, J., Grimmer, T., Halbgebauer, S., Kort, A.M., Lima, M., Marques, T.M., Ortner, M., Santana, I., Steinacker, P., Verbeek, M.M., Volk, A.E., Ludolph, A.C., Otto, M., 2022. Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion. J Neurol Neurosurg Psychiatry.","DOI":"10.1136\/jnnp-2021-328547"},{"key":"10.1016\/j.arr.2024.102485_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer's disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102485_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.arr.2024.102485_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3233\/JAD-230384","article-title":"Pre-analytical variables influencing stability of blood-based biomarkers of neuropathology","volume":"95","author":"Panikkar","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102485_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00068-022-01979-y","article-title":"The diagnostic and prognostic value of glial fibrillary acidic protein in traumatic brain injury: a systematic review and meta-analysis","volume":"49","author":"Pei","year":"2023","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"10.1016\/j.arr.2024.102485_bib45","article-title":"Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression","author":"Pelkmans","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib46","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102485_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-023-01341-3","article-title":"Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study","volume":"15","author":"Perna","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1747493018806167","article-title":"Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: systematic review and meta-analysis of diagnostic test accuracy","volume":"14","author":"Perry","year":"2019","journal-title":"Int J. Stroke"},{"key":"10.1016\/j.arr.2024.102485_bib49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib50","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.1038\/s41467-023-44192-0","article-title":"Mitochondrial malfunction and atrophy of astrocytes in the aged human cerebral cortex","volume":"14","author":"Popov","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102485_bib51","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ana.25874","article-title":"Remote blood biomarkers of longitudinal cognitive outcomes in a population study","volume":"88","author":"Rajan","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib52","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.arr.2024.102485_bib53","doi-asserted-by":"crossref","first-page":"e860","DOI":"10.1212\/WNL.0000000000201597","article-title":"Diagnostic performance and clinical applicability of blood-based biomarkers in a prospective memory clinic cohort","volume":"100","author":"Sarto","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102485_bib54","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1097\/CCM.0000000000003728","article-title":"Prognostic value of glial fibrillary acidic protein in patients with moderate and severe traumatic brain injury: a systematic review and meta-analysis","volume":"47","author":"Shemilt","year":"2019","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.arr.2024.102485_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","article-title":"Plasma glial fibrillary acidic protein in the alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression","volume":"69","author":"Shen","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.arr.2024.102485_bib56","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/ene.15762","article-title":"Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia","volume":"30","author":"Silva-Sp\u00ednola","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2024.102485_bib57","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102485_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib59","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/alz.12806","article-title":"Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability","volume":"18","author":"Simr\u00e9n","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106175","article-title":"Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease","volume":"183","author":"Snellman","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102485_bib61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/brain\/awac128","article-title":"Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease","volume":"146","author":"Stevenson-Hoare","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102485_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/alz.12614","article-title":"Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years","volume":"19","author":"Stocker","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102870","article-title":"A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis","volume":"51","author":"Sun","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102485_bib64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-020-00657-8","article-title":"Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions","volume":"12","author":"Teitsdottir","year":"2020","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib65","article-title":"Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia","volume":"14","author":"Thijssen","year":"2022","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.arr.2024.102485_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2024.102485_bib67","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study","volume":"2","author":"Verberk","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.arr.2024.102485_bib68","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta((1-42\/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology.","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102485_bib70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40364-022-00435-8","article-title":"Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration","volume":"10","author":"Wang","year":"2022","journal-title":"Biomark. Res"},{"key":"10.1016\/j.arr.2024.102485_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13318","article-title":"Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease","author":"Yakoub","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102485_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40035-021-00275-w","article-title":"Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia","volume":"10","author":"Zhu","year":"2021","journal-title":"Transl. Neurodegener."}],"updated-by":[{"DOI":"10.1016\/j.arr.2026.103445","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:00:00Z","timestamp":1794614400000}}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T22:54:54Z","timestamp":1730501694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":72,"alternative-id":["S1568163724003039"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102485","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102485"}}